Odayme Quesada | Medicine and Health Sciences | Research Excellence Award

Published on by Forensic Scientist

Assoc. Prof. Dr. Odayme Quesada | Medicine and Health Sciences | Research Excellence Award

University of Cincinnati, The Christ Hospital | United States

Assoc. Prof. Dr. Odayme Quesada is a clinician-scientist specializing in women’s cardiovascular health, with a strong focus on coronary microvascular and vasomotor dysfunction (CMVD), ANOCA, and MINOCA. Her research integrates innovative diagnostic strategies and targeted therapeutic approaches to improve cardiovascular outcomes in women. She has authored 78 Scopus-indexed publications, achieving 1,615 citations and an h-index of 22. Her scholarly contributions include high-impact journal articles, book chapters, and leadership in multicenter clinical trials. She has advanced specialized research programs and contributed significantly to understanding sex-specific cardiovascular risk factors and disease mechanisms.

                            Citation Metrics (Scopus)

2400

2000

1600

1200

800

400

0

 

Citations
1615
Documents
78
h-index
22

Citations

Documents

h-index

View Scopus Profile  View ORCID Profile

Featured Publications

Fulya Erendor Cihan | Medicine and Health Sciences | Best Review Paper Award

Published on by Forensic Scientist

Assist. Prof. Dr. Fulya Erendor Cihan | Medicine and Health Sciences | Best Review Paper Award

Ordu University | Turkey

Dr. Fulya Erendor Cihan is an emerging researcher in gene and cell therapy, with a strong focus on precision gene editing, viral vector systems, and therapeutic strategies for metabolic and neurodegenerative diseases. Her work integrates advanced molecular biology techniques with translational research, particularly in diabetes, COVID-19 vaccine development, and neuroprotection. She has contributed to multiple nationally funded research projects and international collaborations, emphasizing lentiviral and adenoviral vector-based therapies. Her research outputs include high-impact journal publications, conference proceedings, and book chapters, reflecting her growing influence in biomedical innovation and experimental therapeutics.

                        Citation Metrics (Google Scholar)

300

250

200

150

100

50

0

 

Citations
150
Documents
25
h-index
5

Citations

Documents

h-index

View Google Scholar Profile  View ORCID Profile

Featured Publications


Gene and cell therapy of human genetic diseases: Recent advances and future directions

– Journal of Cellular and Molecular Medicine, 2024 | Cited by: 33

Ebeney Whillas | Medicine and Health Sciences | Research Excellence Award

Published on by Forensic Scientist

Ms. Ebeney Whillas | Medicine and Health Sciences | Research Excellence Award

University of Wollongong | Australia

Ms. Ebeney Whillas is a sports nutrition researcher whose work focuses on nutrition-related experiences during the transition from elite sport to post-competitive life. Her research is grounded in qualitative inquiry, addressing a critical gap in sports nutrition literature by centering the voices of former elite athletes. She is the lead author of a peer-reviewed article published in Nutrients (MDPI), which examines how entrenched sporting cultures continue to shape eating behaviours, health perceptions, and wellbeing after retirement from elite competition. Her scholarship contributes to a growing recognition that athlete nutrition support must extend beyond performance-focused phases to encompass long-term health and adjustment. Ms. Whillas’ research interests include athlete transition, sports nutrition culture, and the relationship between nutrition practices and mental wellbeing. Through her work, she provides evidence to inform more holistic, sustainable, and athlete-centered nutrition interventions across the full athletic lifespan.

Profiles: Sci Profiles | LinkedIn

Featured Publications

• Whillas, E. K., Craddock, J. C., & Lambert, K. (2025). Navigating nutrition beyond elite sport: A qualitative exploration of experiences after retirement. Nutrients, 17(24), Article 3920. https://doi.org/10.3390/nu17243920

Marta Cudzik | Medicine and Health Sciences | Research Excellence Award

Published on by Forensic Scientist

Dr. Marta Cudzik | Medicine and Health Sciences | Research Excellence Award

Institute of Psychiatry and Neurology | Poland

Dr. Marta Cudzik is a psychiatry-focused physician–researcher whose scholarly work lies at the intersection of neuroscience, emotional processing, and obesity-related mental health disorders. Her research examines how affective regulation, emotional intelligence, and trauma-related psychological mechanisms influence vulnerability to depression and other psychiatric conditions. She has authored peer-reviewed studies addressing emotional dysregulation, dissociative defense mechanisms in childhood trauma, and alexithymia among individuals with obesity, contributing clinically relevant insights to contemporary psychiatric research. A central theme of her work is the integration of psychological, neurobiological, and metabolic perspectives to better understand complex mind–body interactions. Dr. Marta Cudzik is developing an emerging interdisciplinary research direction referred to as psycho-obesitology, which seeks to bridge psychiatry and metabolic medicine through evidence-based frameworks. Her research aims to support more holistic diagnostic and therapeutic strategies in mental health, with implications for prevention, personalized treatment, and translational psychiatric care.

Profile: ORCID

Featured Publications

Cudzik, M., Lis, M., Wichniak, A., & Bieńkowski, P. (2026). Alexithymia among patients with obesity: A systematic review. Journal of Psychiatric Research. https://doi.org/10.1016/j.jpsychires.2025.12.030

Cudzik, M., Soroka, E., & Olajossy, M. (2019). The impact of emotional intelligence level on depression vulnerability. Current Problems of Psychiatry, 20(3). https://doi.org/10.2478/cpp-2019-0011

Cudzik, M., Soroka, E., & Olajossy, M. (2019). Dissociative identity disorder as a wide range of defense mechanisms in children with a history of early childhood trauma. Current Problems of Psychiatry, 20(2). https://doi.org/10.2478/cpp-2019-0006

Rama Ayash | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Dr. Rama Ayash | Medicine and Health Sciences | Best Researcher Award

Damascus University | Syria

Dr. Rama Ayash is a medical advisor, senior lecturer, and scientific researcher specializing in clinical biochemistry, diabetes research, and molecular mechanisms of β-cell apoptosis. Her primary research focuses on the pathophysiological role of cytokines and death receptors in glucose dysregulation and prediabetes, with particular emphasis on the therapeutic effects of DPP4 inhibitors such as sitagliptin. Her recent publications include groundbreaking studies in Scientific Reports, BMC Endocrine Disorders, and the European Journal of Pharmacology, exploring inflammatory cytokine modulation, apoptotic biomarkers (FAS, TNFR1, TRAIL-R2), and their relationship to β-cell dysfunction. Dr. Rama Ayash’s research contributions advance understanding of early diabetic mechanisms, aiding in the development of targeted therapeutic strategies to preserve pancreatic function. She has also supervised diverse clinical and molecular research projects in cardiovascular pharmacology, endocrine biomarkers, and celiac disease diagnostics, demonstrating her interdisciplinary expertise. Her work integrates clinical biochemistry, molecular diagnostics, and translational medicine, contributing to the growing field of preventive and precision diabetology. Dr. Rama Ayash has been an active conference speaker and scientific presenter, sharing insights on cardio-renal pharmacology, metabolic pathways, and biomarker discovery. Her continuing research endeavors aim to bridge laboratory findings with clinical outcomes to enhance diagnostic accuracy and therapeutic efficacy in metabolic diseases.

Profiles: Google Scholar | ORCID

Featured Publications

• Ayash, R., Kabalan, Y., & Chamaa, S. (2025). Exploring the predictive potentials of IL-1β and TNFR1 in atherogenic risk in prediabetes. Scientific Reports, 15(1), 37369. https://doi.org/10.1038/s41598-025-37369

• Ayash, R., Kabalan, Y., & Chamaa, S. (2025). Association of soluble apoptotic biomarkers (FAS, TNFR1 and TRAIL-R2) with β-cell dysfunction in early glucose dysregulation. BMC Endocrine Disorders, 25(1), 218. https://doi.org/10.1186/s12902-025-0218

• Ayash, R., Kabalan, Y., & Chamaa, S. (2025). Sitagliptin reduces cytokine-induced β-cell apoptosis in prediabetes: A six-month interventional study. European Journal of Pharmacology, 177708. https://doi.org/10.1016/j.ejphar.2025.177708

Xiaowen Mao | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Assist. Prof. Dr. Xiaowen Mao | Medicine and Health Sciences | Best Researcher Award

University of Macau | Macau

Dr. Xiaowen Mao, M.D., Ph.D., is an Assistant Professor at the State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, where she leads translational research on cancer biology, immunotherapy, and tumor microenvironment modulation. She earned her Ph.D. in Biomedical Sciences from the University of Hong Kong and her B.Sc. in Clinical Medicine from Shanghai Jiao Tong University, China. Her research focuses on extracellular vesicles, immune homeostasis, metabolic reprogramming in tumors, and hepatocellular carcinoma metastasis, integrating molecular, cellular, and translational approaches. Dr. Xiaowen Mao has led several high-impact projects as principal investigator, funded by the Health and Medical Research Fund, National Natural Science Foundation Young Scientist Fund, and FDCT Innovation and Technology Promotion. Her significant contributions include the development of broadly potent neutralizing antibodies targeting Nidogen 1 to inhibit tumor growth, elucidation of extracellular vesicle-mediated metabolic reprogramming in tumors, and advances in dendritic cell vaccine strategies. She holds a U.S. patent on Nidogen 1 as a diagnostic and therapeutic target for hepatocellular carcinoma, serves as Guest Editor for Frontiers in Endocrinology, and is an ad-hoc reviewer for multiple high-impact journals. According to Scopus, she has 31 publications, 1,114 citations by 1,010 documents, and an h-index of 20. Dr. Xiaowen Mao’s work bridges fundamental research and clinical translation, delivering innovative therapies and advancing precision medicine in oncology, while demonstrating a profound impact on cancer biology, immunotherapy, and translational research.

Profile: Scopus

Featured Publications

  • Xue, T. M., Yeung, C. L. S., Mao, X. W., Tey, S. K., Lo, K. W., Tang, H. N., Yun, J. P., & Yam, J. W. P. (2025). Development of a broadly potent neutralizing antibody targeting Nidogen 1 effectively inhibits cancer growth and metastasis in preclinical tumor models. Journal of Translational Internal Medicine. https://doi.org/10.1515/jtim-2025-0008

  • Xia, L., Li, C. G., Zhao, J., Sun, Q. C., & Mao, X. W.* (2025). Rebalancing immune homeostasis in combating disease: The impact of medicine food homology plants and gut microbiome. Phytomedicine, 136, 156150. https://doi.org/10.1016/j.phymed.2025.156150

  • Chen, Z., Yam, J. W. P., & Mao, X. W.* (2024). The multifaceted roles of small extracellular vesicles in metabolic reprogramming in the tumor microenvironments. Proteomics, e2300021. https://doi.org/10.1002/pmic.202300021

  • Lee, K. W., Yam, J. W. P., & Mao, X. W.* (2023). Dendritic cell vaccines: A shift from conventional approach to new generations. Cells, 12(2147). https://doi.org/10.3390/cells12172147

  • Li, S., Delvecchio, M., Ramkumar, K., Mao, X. W., Sun, X. D., & Guo, S. Z. (2023). Editorial: Clinical and genetic determinants of diabetes and complications. Frontiers in Endocrinology.

Swaroop S. Sonone | Medicine and Health Sciences | Best Faculty Award

Published on by Forensic Scientist

Mr. Swaroop S. Sonone | Medicine and Health Sciences | Best Faculty Award

School of Forensic Sciences, JSPM University, Pune | India

Mr. Swaroop S. Sonone, Assistant Professor at the School of Behavioural and Forensic Sciences, Jayawant Shikshan Prasarak Mandal (JSPM) University, Pune, India, is a distinguished academic and researcher specializing in Digital and Cyber Forensics, Forensic Ballistics, and Cyber Psychology. He holds an M.Sc. in Forensic Science (Digital & Cyber Forensics) and a B.Sc. in Forensic Science from Dr. Babasaheb Ambedkar Marathwada University, Aurangabad, along with a Diploma in Photography. He has qualified multiple national eligibility tests, including UGC-NET (three times) and MH-SET (SPPU, 2021), showcasing his academic competence and commitment to higher education. His research credentials, as indexed in Scopus (Author ID: 57219960845; ORCID: 0000-0002-3358-348X), include 24 publications, 670 citations, and an h-index of 5, reflecting his consistent scholarly contribution and scientific impact. Mr. Sonone has demonstrated exemplary academic leadership as Programme Coordinator, IQAC Coordinator, and Editor of the International Journal of Forensic Sciences (IJFSC). His notable publications, such as Water Contamination by Heavy Metals (2020) and Unveiling the Power of Nanoparticles for Latent Fingerprints (2024), highlight his interdisciplinary expertise bridging forensic and environmental sciences. Recognized for his excellence in teaching and research, he received the Young Forensic Faculty Award (NAEF-2025) by ThinkSakshya. Beyond academia, he actively engages in public science communication through national media, fostering forensic awareness. With his intellectual rigor, innovation, and leadership, Mr. Swaroop S. Sonone continues to advance forensic science education and research in India, exemplifying professional excellence and academic integrity.

Profile: Scopus | ORCID | Google Scholar | ResearchGate | LinkedIn | Staff Page

Featured Publications

  • Sonone, S. S., Jadhav, S., Sankhla, M. S., & Kumar, R. (2020). Water contamination by heavy metals and their toxic effect on aquaculture and human health through food chain. Letters in Applied NanoBioScience, 10(2), 2148–2166. Cited by 562.

  • Gulia, S., Rohilla, R. K., Sankhla, M. S., Kumar, R., & Sonone, S. S. (2020). Impact of pesticide toxicity in aquatic environment. Biointerface Research in Applied Chemistry, 11(3), 10131–10140. Cited by 166.

  • Verma, R. K., Sankhla, M. S., Rathod, N. V., Sonone, S. S., Parihar, K., & Singh, G. K. (2022). Eradication of fatal textile industrial dyes by wastewater treatment. Biointerface Research in Applied Chemistry, 12(1), 567–587. Cited by 74.

  • Mohan, H., Rajput, S. S., Jadhav, E. B., Sankhla, M. S., Sonone, S. S., Jadhav, S., et al. (2021). Ecotoxicity, occurrence, and removal of pharmaceuticals and illicit drugs from aquatic systems. Biointerface Research in Applied Chemistry, 11(5), 12530–12546. Cited by 65.

  • Singhal, M., Jadhav, S., Sonone, S. S., Sankhla, M. S., & Kumar, R. (2021). Microalgae-based sustainable bioremediation of water contaminated by pesticides. Biointerface Research in Applied Chemistry, 12, 149–169. Cited by 54.

Long Chang | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Dr. Long Chang | Medicine and Health Sciences | Best Researcher Award

Peking Union Medical College Hospital | China

Dr. Long Chang is an accomplished physician and clinical researcher whose career demonstrates excellence in patient care and significant contributions to hematology. He currently serves as an Attending Physician at the Department of Hematology, Peking Union Medical College Hospital, Beijing, China, building upon his medical training at Peking Union Medical College, Tsinghua University. His research focuses on rare hematologic disorders, particularly myeloproliferative neoplasms and histiocytic diseases, with emphasis on improving diagnostic precision, expanding therapeutic strategies, and enhancing patient outcomes. According to Scopus (Author ID: 57225110413), Dr. Long Chang has authored 39 publications, which have collectively received 165 citations across 152 documents, reflecting the impact of his work, and holds an h-index of 6. He has published influential studies in leading journals including Leukemia, EClinicalMedicine, Oncologist, and Orphanet Journal of Rare Diseases. His work has advanced treatment options for Rosai-Dorfman disease and Langerhans cell histiocytosis while also providing novel insights into gamma heavy chain disease. Notably, his clinical trials have introduced promising approaches such as low-dose cytarabine and novel immunomodulatory therapies, offering alternatives for conditions with limited treatments. Beyond publications, Dr. Long Chang demonstrates commitment to translational medicine by bridging molecular research with patient-centered care. Recognized by peers for his rigor, innovation, and leadership, he has progressed from Resident and Chief Resident to Attending Physician, reflecting both clinical expertise and academic excellence. With impactful contributions influencing practice worldwide, Dr. Long Chang exemplifies the qualities of a dedicated physician-scientist whose work continues to advance the frontiers of hematology.

Profile: Scopus

Featured Publications

  • Chang, L., Zhou, D. B., & Cao, X. X. (2023). Gamma heavy chain disease: A retrospective analysis of 6 cases. Orphanet Journal of Rare Diseases, 18(1), 77.

  • Chang, L., Qiao, B., Cai, H., et al. (2023). Clinical phenotypes, molecular analysis, and outcomes of patients with Rosai-Dorfman disease. Leukemia, 37(11), 2297–2300.

  • Chang, L., Lang, M., Lin, H., et al. (2024). Phase 2 study using low dose cytarabine for adult patients with newly diagnosed Langerhans cell histiocytosis. Leukemia, 38(4), 803–809.

  • Chang, L., Lang, M., Liu, T., et al. (2024). Lenalidomide and dexamethasone for Rosai-Dorfman disease: A single arm, single center, prospective phase 2 study. EClinicalMedicine, 73, 102685.

  • Chang, L., Cai, H. C., Lang, M., et al. (2024). Liver involvement with Langerhans cell histiocytosis in adults. The Oncologist. Advance online publication.

Zhechun Wu | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Mr. Zhechun Wu | Medicine and Health Sciences | Best Researcher Award

Chaoyang Hospital | China

Mr. Zhechun Wu is a resident physician in the Department of Urology at Beijing Chaoyang Hospital, Capital Medical University, Beijing, China, who has established himself as an emerging clinician–scientist combining medical training with impactful research. He earned his Bachelor of Science degree from Capital Medical University and is currently advancing his clinical expertise through residency while contributing to translational oncology research. His work is focused on prostate cancer, with particular emphasis on identifying therapeutic targets that regulate tumor immunity, a critical area for developing next-generation treatment strategies. Mr. Zhechun Wu has published in reputable international journals, including a recent article in Investigational New Drugs that explored drug targets modulating tumor immune response, a study that has already been cited in related scholarly work, reflecting its scientific significance. His projects are supported by competitive funding from the National Natural Science Foundation of China  and the Beijing Natural Science Foundation, highlighting his ability to secure prestigious grants and deliver research with clinical and academic value. Alongside research, his clinical practice in urology, oncology, and kidney transplantation strengthens his understanding of patient-centered challenges, allowing him to align laboratory findings with real-world medical needs. This dual role as physician and researcher equips him to contribute to both advancing cancer therapeutics and improving clinical outcomes, establishing a foundation for future leadership in medical innovation and academic research.

Profile: ORCID

Featured Publications

Zhang, Y., Qiu, X., Wu, Z., Li, Y., Shen, X., Wu, J., Cao, P., Sun, Z., & Wang, W. (2025). Comprehensive analysis of the association between volatile organic compound pollutants and chronic kidney disease in hypertensive populations: Insights from multi-omics approaches and identification of potential therapeutic targets. Environmental Research, 121966.

Wu, Z., Li, S., Li, Y., Wang, Z., & Wang, W. (2025). Identifying potential therapeutic targets for prostate cancer with mediating role in tumor immunity. Discover Oncology, 16, 98.

Wu, Z. (2025). Higher sexual frequency correlated with lowered PSA complex levels in U.S. men over 40 and without prostate conditions: A nationwide cross-sectional study. The Journal of Sexual Medicine.

Yan Bai | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Dr. Yan Bai | Medicine and Health Sciences | Best Researcher Award

Yunnan University | China

Dr. Yan Bai is a highly accomplished postdoctoral researcher at the State Key Laboratory of Conservation and Utilization of Bio-resources in Yunnan and the Center for Life Sciences, School of Life Sciences, Yunnan University, Kunming, China. She earned her PhD in Cell Biology from Yunnan University, MSc in Pharmacology from the Chinese PLA Medical Academy, and BSc in Pharmacy from Dali University, establishing a strong interdisciplinary foundation spanning pharmacology, microbiology, and cellular biology. Prior to her current role, she conducted research at the Chinese PLA General Hospital, focusing on combination therapies against multidrug-resistant bacteria. Her research primarily investigates mitochondrial homeostasis, tumor biology, and the molecular mechanisms underlying mitochondrial genetic diseases, with particular attention to mitochondria-associated condensates (MATOs) as regulators of protein translation and mitochondrial integrity. Dr. Yan Bai has led and contributed to several major research projects, including grants from the National Natural Science Foundation of China, the National Basic Research Program, and Yunnan Province Science and Technology initiatives. Her work has resulted in high-impact publications in journals such as Nature Aging (2025), Sci China Life Sci (2025), EMBO J (2024), and Biophys Rep (2024). According to Scopus, she has authored 10 publications, cited 177 times across 169 documents, with an h-index of 6, demonstrating both productivity and influence in her field. Through her interdisciplinary collaborations, innovative experimental approaches, and groundbreaking findings on mitochondrial regulation and aging, Dr. Yan Bai has made significant contributions to biomedical science, advancing understanding of mitochondrial biology, disease mechanisms, and translational biomedical applications.

Profile: Scopus

Featured Publications

Bai, Y., Ma, T., Zhao, S., Li, S., Wang, X., Li, J., Sun, W., Yang, Y., Liu, F., Shan, Q., Qin, Z., Liu, N., Zhang, J., Tian, F., Duan, M., Chen, S., Lai, F., Chen, Q., Wu, X., & Yang, C. (2025). Mitochondria-associated condensates maintain mitochondrial homeostasis and promote lifespan. Nature Aging.

Hao, Q., Bai, Y., Guan, R., Dong, R., Bai, W., Hamdy, H., Wang, L., Meng, M., Sun, Y., Shen, J., & Sun, J. (2025). VPS35/Retromer-dependent MT1-MMP regulation confers melanoma metastasis. Science China Life Sciences, 68(7), 1996–2009.

Hao, Q., Dong, R., Bai, W., Chang, D., Yao, X., Zhang, Y., Xu, H., Li, H., Kui, X., Wang, F., Wang, Y., Wang, C., Lei, Y., Chen, Y., Shen, J., Sang, L., Bai, Y., & Sun, J. (2024). Screening for metastasis-related genes in mouse melanoma cells through sequential tail vein injection. Biophysical Reports, 10(1), 15–21.

Liu, F., Li, T., Gong, H., Tian, F., Bai, Y., Wang, H., Yang, C., Li, Y., Guo, F., Liu, S., & Chen, Q. (2024). Structural insights into the molecular effects of the anthelmintics monepantel and betaine on the Caenorhabditis elegans acetylcholine receptor ACR-23. EMBO Journal, 43(17), 3787–3806.

Wang, T., Zhou, X., Bai, Y., Zhang, L., Li, L., & Wu, C. (2018). Antiepileptic effect of uridine may be caused by regulating dopamine release and receptor expression in corpus striatum. Brain Research, 1688, 47–53.

Bai, Y., Liu, B., Wang, T., Cai, Y., Liang, B., Wang, R., Liu, Y., & Wang, J. (2015). In vitro activities of combinations of rifampin with other antimicrobials against multidrug-resistant Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy, 59(3), 1466–1471.

Liu, B., Bai, Y., Liu, Y., Di, X., Zhang, X., Wang, R., & Wang, J. (2015). In vitro activity of tigecycline in combination with cefoperazone-sulbactam against multidrug-resistant Acinetobacter baumannii. Journal of Chemotherapy, 27(5), 271–276.